Literature DB >> 19960454

Angiostatic effects of Brazilian green propolis and its chemical constituents.

Yuichi Chikaraishi1, Hiroshi Izuta, Masamitsu Shimazawa, Satoshi Mishima, Hideaki Hara.   

Abstract

Propolis, a resinous substance collected by honeybees from various plant sources, has several pharmacological actions, such as anti-tumor and anti-inflammatory effects. The aim of this study was to evaluate the anti-angiogenic effects of a water extract of Brazilian green propolis (WEP) and its constituents, caffeoylquinic acid derivatives, against angiogenic processes in human umbilical vein endothelial cells (HUVECs) in vitro. We also examined the anti-angiogenic effects of WEP against retinal neovascularization in a murine oxygen-induced retinopathy model in vivo. WEP and its constituents significantly suppressed vascular endothelial growth factor (VEGF)-induced HUVEC proliferation, migration, and tube formation in vitro. WEP and its caffeoylquinic acid derivatives suppressed VEGF-stimulated phosphorylation of mitogen-activated protein kinase in HUVECs (versus VEGF alone). Moreover, WEP (300 mg/kg/day, subcutaneously for 5 days) significantly suppressed retinal neovascularization in the murine oxygen-induced retinopathy model. These data indicate that (i) WEP has angiostatic effects against angiogenic processes in vitro and in an in vivo model of murine oxygen-induced retinopathy and (ii) the inhibitory effects of WEP against in vitro angiogenesis are chiefly derived from its caffeoylquinic acid derivatives. Judging from these findings, WEP and its caffeoylquinic acid derivatives may represent candidates for preventive or therapeutic agents against diseases caused by angiogenesis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19960454     DOI: 10.1002/mnfr.200900115

Source DB:  PubMed          Journal:  Mol Nutr Food Res        ISSN: 1613-4125            Impact factor:   5.914


  7 in total

Review 1.  The immunomodulatory and anticancer properties of propolis.

Authors:  Godfrey Chi-Fung Chan; Ka-Wai Cheung; Daniel Man-Yuen Sze
Journal:  Clin Rev Allergy Immunol       Date:  2013-06       Impact factor: 8.667

Review 2.  Propolis: An update on its chemistry and pharmacological applications.

Authors:  Rajib Hossain; Cristina Quispe; Rasel Ahmed Khan; Abu Saim Mohammad Saikat; Pranta Ray; Damira Ongalbek; Balakyz Yeskaliyeva; Divya Jain; Antonella Smeriglio; Domenico Trombetta; Roghayeh Kiani; Farzad Kobarfard; Naheed Mojgani; Parvaneh Saffarian; Seyed Abdulmajid Ayatollahi; Chandan Sarkar; Mohammad Torequl Islam; Dılhun Keriman; Arserim Uçar; Miquel Martorell; Antoni Sureda; Gianfranco Pintus; Monica Butnariu; Javad Sharifi-Rad; William C Cho
Journal:  Chin Med       Date:  2022-08-26       Impact factor: 4.546

Review 3.  An Insight into Anticancer Effect of Propolis and Its Constituents: A Review of Molecular Mechanisms.

Authors:  Perumal Elumalai; Natarajan Muninathan; Sadhasivan T Megalatha; Arumugam Suresh; Kalimuthu Senthil Kumar; Nathan Jhansi; Kuppuswamy Kalaivani; Gunasekaran Krishnamoorthy
Journal:  Evid Based Complement Alternat Med       Date:  2022-06-17       Impact factor: 2.650

Review 4.  The Cardiovascular Therapeutic Potential of Propolis-A Comprehensive Review.

Authors:  Henrique Silva; Rafaela Francisco; Ariana Saraiva; Simone Francisco; Conrado Carrascosa; António Raposo
Journal:  Biology (Basel)       Date:  2021-01-04

5.  Bee products prevent VEGF-induced angiogenesis in human umbilical vein endothelial cells.

Authors:  Hiroshi Izuta; Masamitsu Shimazawa; Kazuhiro Tsuruma; Yoko Araki; Satoshi Mishima; Hideaki Hara
Journal:  BMC Complement Altern Med       Date:  2009-11-17       Impact factor: 3.659

6.  Polyphenols Isolated from Propolis Augment TRAIL-Induced Apoptosis in Cancer Cells.

Authors:  Ewelina Szliszka; Wojciech Krol
Journal:  Evid Based Complement Alternat Med       Date:  2013-03-19       Impact factor: 2.629

7.  ERK1/2 and HIF1α Are Involved in Antiangiogenic Effect of Polyphenols-Enriched Fraction from Chilean Propolis.

Authors:  Alejandro Cuevas; Nicolás Saavedra; Martina Rudnicki; Dulcineia S P Abdalla; Luis A Salazar
Journal:  Evid Based Complement Alternat Med       Date:  2015-08-10       Impact factor: 2.629

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.